Skip to content

Effect of intravenous lidocaine for reduction of nociplastic low back pain

Effect Of Intravenous Lidocaine In Chronic Nociplastic Non-specific Low Back Pain - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070888
Enrollment
80
Registered
2024-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M545- Low back pain

Interventions

Intervention1: Intravenous lidocaine infusion compared to normal saline infusion in chronic nociplastic non-specific low back pain: 2% intravenous lidocaine or 0.9% normal saline infusion weekly for

Sponsors

NRS Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients from out-patient department during the study period who are clinically diagnosed cases of chronic non-specific low back pain [Pain occurring primarily in the back with no signs of a serious underlying condition (such as cancer, infection, or cauda equina syndrome etc. ), spinal stenosis or radiculopathy, or another specific spinal cause (such as vertebral compression fracture or ankylosing spondylitis etc. )]

Exclusion criteria

Exclusion criteria: Trauma. Fibromyalgia, Chronic fatigue syndrome. Rheumatological disorders. Impaired renal, cardiac and hepatic function. Pregnant female and Females who desire to have pregnancy during the study period. Major Neuromuscular disorders. Major metabolic disorders. Major Psychiatric disorders. Drug Hypersensitivity. Conditions not satisfying inclusion criteria. Patients not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
Reduction of pain by using VAS scoring system Timepoint: 1, 3, 6 months

Secondary

MeasureTime frame
1.Improvement in sleep using Pittsburgh Sleep Quality Index (PSQI) 2.Functional disability using Quebec Back Pain Disability Scale (QBPDS)Timepoint: 1, 3, 6 months

Countries

India

Contacts

Public ContactPARTHA PRATIM DAS

Nil Ratan Sircar Medical College and Hospital

drppdaspmr74@gmail.com9433943719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026